This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goldstick, L. Articles by Bode, R. Search for Related Content PubMed PubMed Citation Articles by Goldstick, L. Articles by Bode, R.

NEUROLOGY 1985;35:103
© 1985 American Academy of Neurology

Spinal cord degeneration in AIDS

L. Goldstick, MD, T. I. Mandybur, MD, PhD and R. Bode, MD

Department of Neurology (Dr. Goldstick), the Department of Pathology and Laboratory Medicine (Dr. Mandybur), and the Department of Internal Medicine (Dr. Bode), University of Cincinnati College of Medicine, Cincinnati, OH.

Ten months before his death, a 36-year-old homosexual man with AIDS developed progressive symmetric paraparesis with muscle wasting, paresthesias, reflex-uninhibited bladder function, and bowel incontinence. Neuropathologic postmortem examination revealed a symmetric degeneration of the lateral and anterior pyramidal tracts as well as the posterior columns. Scattered microglial nodules were present in the brain and spinal cord. The cause of this spinal cord complication remains uncertain. Possible etiologies of the demyelinating process include infectious, parainfectious, nutritional, paraneoplastic, and toxic causes.

Address correspondence and reprint requests to Dr. Mandybur, Department of Pathulogy (Neuropathology), Mail Location 533, University of Cincinnati Medical Center, Cincinnati, OH 45267.

Accepted for publication April 13, 1984

This article has been cited by other articles:

				A. Di Rocco, P. Werner, T. Bottiglieri, J. Godbold, M. Liu, M. Tagliati, A. Scarano, and D. Simpson Treatment of AIDS-associated myelopathy with L-methionine: A placebo-controlled study Neurology, October 12, 2004; 63(7): 1270 - 1275. [Abstract] [Full Text] [PDF]

				A. Moulignier, A. Moulonguet, G. Pialoux, and W. Rozenbaum Reversible ALS-like disorder in HIV infection Neurology, September 25, 2001; 57(6): 995 - 1001. [Abstract] [Full Text] [PDF]

				J. Chong, A. D. Rocco, M. Tagliati, F. Danisi, D. M. Simpson, and S. W. Atlas MR Findings in AIDS-Associated Myelopathy AJNR Am. J. Neuroradiol., September 1, 1999; 20(8): 1412 - 1416. [Abstract] [Full Text]

				M. A. Pagano, P. E. Cahn, M. L. Garau, C. A. Mangone, H. A. Figini, A. A. Yorio, M. C. Dellepiane, M. G. Amores, H. M. Perez, and A. D. Casiro Brain-Stem Auditory Evoked Potentials in Human Immunodeficiency Virus-Seropositive Patients With and Without Acquired Immunodeficiency Syndrome Arch Neurol, February 1, 1992; 49(2): 166 - 169. [Abstract] [PDF]

				K. D. Kieburtz, D. W. Giang, R. B. Schiffer, and N. Vakil Abnormal Vitamin B12 Metabolism in Human Immunodeficiency Virus Infection: Association With Neurological Dysfunction Arch Neurol, March 1, 1991; 48(3): 312 - 314. [Abstract] [PDF]

				R. M. Woolsey, T. J. Chambers, H. D. Chung, and J. D. McGarry Mycobacterial Meningomyelitis Associated With Human Immunodeficiency Virus Infection Arch Neurol, June 1, 1988; 45(6): 691 - 693. [Abstract] [PDF]

				D. H. GABUZDA and M. S. HIRSCH Neurologic Manifestations of Infection with Human Immunodeficiency Virus: Clinical Features and Pathogenesis Ann Intern Med, September 1, 1987; 107(3): 383 - 391. [Abstract] [PDF]

				G. C. Roman Retrovirus-Associated Myelopathies Arch Neurol, June 1, 1987; 44(6): 659 - 663. [Abstract] [PDF]

				M. H. Stoler, T. A. Eskin, S. Benn, R. C. Angerer, and L. M. Angerer Human T-Cell Lymphotropic Virus Type III Infection of the Central Nervous System: A Preliminary In Situ Analysis JAMA, November 7, 1986; 256(17): 2360 - 2364. [Abstract] [PDF]